1. Home
  2. SLNG vs MNOV Comparison

SLNG vs MNOV Comparison

Compare SLNG & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stabilis Solutions Inc.

SLNG

Stabilis Solutions Inc.

HOLD

Current Price

$4.10

Market Cap

103.2M

Sector

Utilities

ML Signal

HOLD

Logo Medicinova Inc

MNOV

Medicinova Inc

HOLD

Current Price

$1.40

Market Cap

66.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLNG
MNOV
Founded
2013
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
103.2M
66.9M
IPO Year
2019
2004

Fundamental Metrics

Financial Performance
Metric
SLNG
MNOV
Price
$4.10
$1.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$10.00
$7.50
AVG Volume (30 Days)
72.4K
56.5K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
2400.00
N/A
EPS
N/A
N/A
Revenue
$68,245,000.00
$2,360,807.00
Revenue This Year
$8.66
N/A
Revenue Next Year
$14.31
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
194.15
52 Week Low
$3.21
$1.13
52 Week High
$6.36
$1.96

Technical Indicators

Market Signals
Indicator
SLNG
MNOV
Relative Strength Index (RSI) 51.62 46.76
Support Level $4.36 $1.21
Resistance Level $5.13 $1.43
Average True Range (ATR) 0.46 0.06
MACD 0.12 -0.00
Stochastic Oscillator 76.74 26.41

Price Performance

Historical Comparison
SLNG
MNOV

About SLNG Stabilis Solutions Inc.

Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. It has a geographical presence in the United States and Mexico.

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.

Share on Social Networks: